Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

TLX vs LNTH vs RNW vs AGEN vs GE

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
TLX
Telix Pharmaceuticals Limited

Biotechnology

HealthcareNASDAQ • AU
Market Cap$3.57B
5Y Perf.-35.2%
LNTH
Lantheus Holdings, Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • US
Market Cap$6.06B
5Y Perf.+4.2%
RNW
ReNew Energy Global Plc

Renewable Utilities

UtilitiesNASDAQ • GB
Market Cap$1.38B
5Y Perf.-6.8%
AGEN
Agenus Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$135M
5Y Perf.+11.7%
GE
GE Aerospace

Aerospace & Defense

IndustrialsNYSE • US
Market Cap$310.47B
5Y Perf.+63.1%

TLX vs LNTH vs RNW vs AGEN vs GE — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
TLX logoTLX
LNTH logoLNTH
RNW logoRNW
AGEN logoAGEN
GE logoGE
IndustryBiotechnologyDrug Manufacturers - Specialty & GenericRenewable UtilitiesBiotechnologyAerospace & Defense
Market Cap$3.57B$6.06B$1.38B$135M$310.47B
Revenue (TTM)$1.66B$1.55B$129.66B$114M$48.35B
Net Income (TTM)$66M$279M$11.97B$115K$8.66B
Gross Margin61.6%60.5%77.9%35.7%34.8%
Operating Margin7.1%18.8%48.4%-17.7%18.5%
Forward P/E167.1x17.7x0.4x2.9x39.3x
Total Debt$581M$738K$732.28B$10M$20.49B
Cash & Equiv.$710M$359M$40.42B$3M$12.39B

TLX vs LNTH vs RNW vs AGEN vs GELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

TLX
LNTH
RNW
AGEN
GE
StockNov 24May 26Return
Telix Pharmaceutica… (TLX)10064.8-35.2%
Lantheus Holdings, … (LNTH)100104.2+4.2%
ReNew Energy Global… (RNW)10093.2-6.8%
Agenus Inc. (AGEN)100111.7+11.7%
GE Aerospace (GE)100163.1+63.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: TLX vs LNTH vs RNW vs AGEN vs GE

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: LNTH leads in 3 of 7 categories (5-stock set), making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. GE Aerospace is the stronger pick specifically for dividend income and shareholder returns and recent price momentum and sentiment. TLX and RNW also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
TLX
Telix Pharmaceuticals Limited
The Income Pick

TLX ranks third and is worth considering specifically for income & stability and growth exposure.

  • Dividend streak 1 yrs, beta 0.88
  • Rev growth 55.8%, EPS growth 7.7%, 3Y rev CAGR 368.9%
  • 55.8% revenue growth vs LNTH's 0.5%
Best for: income & stability and growth exposure
LNTH
Lantheus Holdings, Inc.
The Long-Run Compounder

LNTH carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.

  • 42.9% 10Y total return vs GE's 117.1%
  • Lower volatility, beta 0.45, Low D/E 0.1%, current ratio 2.70x
  • Beta 0.45, current ratio 2.70x
  • 18.0% margin vs AGEN's 0.1%
Best for: long-term compounding and sleep-well-at-night
RNW
ReNew Energy Global Plc
The Value Play

RNW is the clearest fit if your priority is value.

  • Lower P/E (0.4x vs 39.3x)
Best for: value
AGEN
Agenus Inc.
The Value Angle

Among these 5 stocks, AGEN doesn't own a clear edge in any measured category.

Best for: healthcare exposure
GE
GE Aerospace
The Income Pick

GE is the #2 pick in this set and the best alternative if dividends and momentum is your priority.

  • 0.5% yield; 2-year raise streak; the other 4 pay no meaningful dividend
  • +39.3% vs TLX's -37.4%
Best for: dividends and momentum
See the full category breakdown
CategoryWinnerWhy
GrowthTLX logoTLX55.8% revenue growth vs LNTH's 0.5%
ValueRNW logoRNWLower P/E (0.4x vs 39.3x)
Quality / MarginsLNTH logoLNTH18.0% margin vs AGEN's 0.1%
Stability / SafetyLNTH logoLNTHBeta 0.45 vs AGEN's 2.58
DividendsGE logoGE0.5% yield; 2-year raise streak; the other 4 pay no meaningful dividend
Momentum (1Y)GE logoGE+39.3% vs TLX's -37.4%
Efficiency (ROA)LNTH logoLNTH12.4% ROA vs AGEN's 0.1%

TLX vs LNTH vs RNW vs AGEN vs GE — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

TLXTelix Pharmaceuticals Limited
FY 2018
Digital Product Sales
88.0%$36M
Digital Product Lease And Maintenance
12.0%$5M
LNTHLantheus Holdings, Inc.
FY 2025
Product
33.4%$1.5B
Radiopharmaceutical Oncology
21.9%$989M
PYLARIFY
21.9%$989M
Total Precision Diagnostics
10.9%$493M
DEFINITY
7.3%$330M
Techne Lite
1.9%$87M
Strategic Partnerships And Other
1.3%$59M
Other (2)
1.3%$59M
RNWReNew Energy Global Plc
FY 2024
Power
85.8%$81.6B
Sale of goods
13.9%$13.2B
Other Revenue
0.4%$350M
AGENAgenus Inc.
FY 2025
Non Cash Royalty Revenue
99.1%$109M
Other
0.9%$1M
GEGE Aerospace
FY 2025
Operating Segments
95.7%$43.9B
Capital Segment
4.3%$2.0B

TLX vs LNTH vs RNW vs AGEN vs GE — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLLNTHLAGGINGAGEN

Income & Cash Flow (Last 12 Months)

RNW leads this category, winning 3 of 6 comparable metrics.

RNW is the larger business by revenue, generating $129.7B annually — 1135.4x AGEN's $114M. LNTH is the more profitable business, keeping 18.0% of every revenue dollar as net income compared to AGEN's 0.1%.

MetricTLX logoTLXTelix Pharmaceuti…LNTH logoLNTHLantheus Holdings…RNW logoRNWReNew Energy Glob…AGEN logoAGENAgenus Inc.GE logoGEGE Aerospace
RevenueTrailing 12 months$1.7B$1.5B$129.7B$114M$48.4B
EBITDAEarnings before interest/tax$132M$347M$86.9B-$10M$9.9B
Net IncomeAfter-tax profit$66M$279M$12.0B$115,000$8.7B
Free Cash FlowCash after capex$45M$372M-$23.8B-$159M$7.5B
Gross MarginGross profit ÷ Revenue+61.6%+60.5%+77.9%+35.7%+34.8%
Operating MarginEBIT ÷ Revenue+7.1%+18.8%+48.4%-17.7%+18.5%
Net MarginNet income ÷ Revenue+4.0%+18.0%+9.2%+0.1%+17.9%
FCF MarginFCF ÷ Revenue+2.7%+24.0%-18.4%-139.1%+15.4%
Rev. Growth (YoY)Latest quarter vs prior year+2.1%+1.2%+37.2%+27.5%+24.7%
EPS Growth (YoY)Latest quarter vs prior year-130.9%+76.5%+94.8%+85.3%-1.1%
RNW leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

RNW leads this category, winning 3 of 6 comparable metrics.

At 27.3x trailing earnings, LNTH trades at a 74% valuation discount to TLX's 105.7x P/E. On an enterprise value basis, RNW's 11.3x EV/EBITDA is more attractive than TLX's 54.9x.

MetricTLX logoTLXTelix Pharmaceuti…LNTH logoLNTHLantheus Holdings…RNW logoRNWReNew Energy Glob…AGEN logoAGENAgenus Inc.GE logoGEGE Aerospace
Market CapShares × price$3.6B$6.1B$1.4B$135M$310.5B
Enterprise ValueMkt cap + debt − cash$3.5B$5.7B$8.7B$142M$318.6B
Trailing P/EPrice ÷ TTM EPS105.68x27.29x48.63x-1123.53x36.42x
Forward P/EPrice ÷ next-FY EPS est.167.14x17.70x0.41x2.94x39.27x
PEG RatioP/E ÷ EPS growth rate3.08x
EV / EBITDAEnterprise value multiple54.93x14.96x11.33x31.89x
Price / SalesMarket cap ÷ Revenue6.32x3.93x1.35x1.18x6.77x
Price / BookPrice ÷ Book value/share8.99x5.84x1.48x16.78x
Price / FCFMarket cap ÷ FCF172.51x17.11x42.74x
RNW leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

LNTH leads this category, winning 6 of 9 comparable metrics.

GE delivers a 45.8% return on equity — every $100 of shareholder capital generates $46 in annual profit, vs $8 for RNW. LNTH carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to RNW's 5.59x. On the Piotroski fundamental quality scale (0–9), AGEN scores 6/9 vs RNW's 4/9, reflecting solid financial health.

MetricTLX logoTLXTelix Pharmaceuti…LNTH logoLNTHLantheus Holdings…RNW logoRNWReNew Energy Glob…AGEN logoAGENAgenus Inc.GE logoGEGE Aerospace
ROE (TTM)Return on equity+15.6%+24.3%+8.4%+45.8%
ROA (TTM)Return on assets+5.5%+12.4%+1.2%+0.1%+6.8%
ROICReturn on invested capital+25.5%+30.6%+4.9%+24.7%
ROCEReturn on capital employed+11.5%+17.1%+6.9%+9.6%
Piotroski ScoreFundamental quality 0–955466
Debt / EquityFinancial leverage1.02x0.00x5.59x1.08x
Net DebtTotal debt minus cash-$129M-$358M$691.9B$7M$8.1B
Cash & Equiv.Liquid assets$710M$359M$40.4B$3M$12.4B
Total DebtShort + long-term debt$581M$738,000$732.3B$10M$20.5B
Interest CoverageEBIT ÷ Interest expense4.31x15.83x86.76x1.11x11.69x
LNTH leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

GE leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in GE five years ago would be worth $45,251 today (with dividends reinvested), compared to $635 for AGEN. Over the past 12 months, GE leads with a +39.3% total return vs TLX's -37.4%. The 3-year compound annual growth rate (CAGR) favors GE at 55.1% vs AGEN's -50.7% — a key indicator of consistent wealth creation.

MetricTLX logoTLXTelix Pharmaceuti…LNTH logoLNTHLantheus Holdings…RNW logoRNWReNew Energy Glob…AGEN logoAGENAgenus Inc.GE logoGEGE Aerospace
YTD ReturnYear-to-date+40.2%+38.3%-4.1%+18.3%-7.2%
1-Year ReturnPast 12 months-37.4%+15.7%-12.7%+25.7%+39.3%
3-Year ReturnCumulative with dividends-29.5%-1.9%+8.7%-88.0%+273.2%
5-Year ReturnCumulative with dividends-29.5%+338.1%-43.3%-93.7%+352.5%
10-Year ReturnCumulative with dividends-29.5%+4289.6%-48.5%-94.2%+117.1%
CAGR (3Y)Annualised 3-year return-11.0%-0.6%+2.8%-50.7%+55.1%
GE leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

LNTH leads this category, winning 2 of 2 comparable metrics.

LNTH is the less volatile stock with a 0.45 beta — it tends to amplify market swings less than AGEN's 2.58 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LNTH currently trades 98.1% from its 52-week high vs AGEN's 52.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricTLX logoTLXTelix Pharmaceuti…LNTH logoLNTHLantheus Holdings…RNW logoRNWReNew Energy Glob…AGEN logoAGENAgenus Inc.GE logoGEGE Aerospace
Beta (5Y)Sensitivity to S&P 5000.88x0.45x0.69x2.58x1.19x
52-Week HighHighest price in past year$18.49$94.86$8.24$7.34$348.48
52-Week LowLowest price in past year$6.30$47.25$4.38$2.71$210.51
% of 52W HighCurrent price vs 52-week peak+57.8%+98.1%+68.2%+52.0%+85.3%
RSI (14)Momentum oscillator 0–10056.369.961.346.154.5
Avg Volume (50D)Average daily shares traded230K872K739K822K5.7M
LNTH leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

GE leads this category, winning 1 of 1 comparable metric.

Analyst consensus: TLX as "Buy", LNTH as "Buy", RNW as "Buy", AGEN as "Buy", GE as "Buy". Consensus price targets imply 91.9% upside for AGEN (target: $7) vs 6.7% for LNTH (target: $99). GE is the only dividend payer here at 0.46% yield — a key consideration for income-focused portfolios.

MetricTLX logoTLXTelix Pharmaceuti…LNTH logoLNTHLantheus Holdings…RNW logoRNWReNew Energy Glob…AGEN logoAGENAgenus Inc.GE logoGEGE Aerospace
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuyBuy
Price TargetConsensus 12-month target$17.00$99.25$6.52$7.33$386.20
# AnalystsCovering analysts51761134
Dividend YieldAnnual dividend ÷ price+0.5%
Dividend StreakConsecutive years of raises10112
Dividend / ShareAnnual DPS$1.36
Buyback YieldShare repurchases ÷ mkt cap0.0%+5.0%0.0%+0.1%+2.4%
GE leads this category, winning 1 of 1 comparable metric.
Key Takeaway

RNW leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). LNTH leads in 2 (Profitability & Efficiency, Risk & Volatility).

Best OverallLantheus Holdings, Inc. (LNTH)Leads 2 of 6 categories
Loading custom metrics...

TLX vs LNTH vs RNW vs AGEN vs GE: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is TLX or LNTH or RNW or AGEN or GE a better buy right now?

For growth investors, Telix Pharmaceuticals Limited (TLX) is the stronger pick with 55.

8% revenue growth year-over-year, versus 0. 5% for Lantheus Holdings, Inc. (LNTH). Lantheus Holdings, Inc. (LNTH) offers the better valuation at 27. 3x trailing P/E (17. 7x forward), making it the more compelling value choice. Analysts rate Telix Pharmaceuticals Limited (TLX) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — TLX or LNTH or RNW or AGEN or GE?

On trailing P/E, Lantheus Holdings, Inc.

(LNTH) is the cheapest at 27. 3x versus Telix Pharmaceuticals Limited at 105. 7x. On forward P/E, ReNew Energy Global Plc is actually cheaper at 0. 4x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — TLX or LNTH or RNW or AGEN or GE?

Over the past 5 years, GE Aerospace (GE) delivered a total return of +352.

5%, compared to -93. 7% for Agenus Inc. (AGEN). Over 10 years, the gap is even starker: LNTH returned +42. 9% versus AGEN's -94. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — TLX or LNTH or RNW or AGEN or GE?

By beta (market sensitivity over 5 years), Lantheus Holdings, Inc.

(LNTH) is the lower-risk stock at 0. 45β versus Agenus Inc. 's 2. 58β — meaning AGEN is approximately 468% more volatile than LNTH relative to the S&P 500. On balance sheet safety, Lantheus Holdings, Inc. (LNTH) carries a lower debt/equity ratio of 0% versus 6% for ReNew Energy Global Plc — giving it more financial flexibility in a downturn.

05

Which is growing faster — TLX or LNTH or RNW or AGEN or GE?

By revenue growth (latest reported year), Telix Pharmaceuticals Limited (TLX) is pulling ahead at 55.

8% versus 0. 5% for Lantheus Holdings, Inc. (LNTH). On earnings-per-share growth, the picture is similar: Telix Pharmaceuticals Limited grew EPS 769. 6% year-over-year, compared to -21. 8% for Lantheus Holdings, Inc.. Over a 3-year CAGR, TLX leads at 368. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — TLX or LNTH or RNW or AGEN or GE?

GE Aerospace (GE) is the more profitable company, earning 19.

0% net margin versus 0. 1% for Agenus Inc. — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RNW leads at 53. 5% versus -18. 0% for AGEN. At the gross margin level — before operating expenses — RNW leads at 91. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is TLX or LNTH or RNW or AGEN or GE more undervalued right now?

On forward earnings alone, ReNew Energy Global Plc (RNW) trades at 0.

4x forward P/E versus 167. 1x for Telix Pharmaceuticals Limited — 166. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AGEN: 91. 9% to $7. 33.

08

Which pays a better dividend — TLX or LNTH or RNW or AGEN or GE?

In this comparison, GE (0.

5% yield) pays a dividend. TLX, LNTH, RNW, AGEN do not pay a meaningful dividend and should not be held primarily for income.

09

Is TLX or LNTH or RNW or AGEN or GE better for a retirement portfolio?

For long-horizon retirement investors, Lantheus Holdings, Inc.

(LNTH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 45)). Agenus Inc. (AGEN) carries a higher beta of 2. 58 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LNTH: +42. 9%, AGEN: -94. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between TLX and LNTH and RNW and AGEN and GE?

These companies operate in different sectors (TLX (Healthcare) and LNTH (Healthcare) and RNW (Utilities) and AGEN (Healthcare) and GE (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: TLX is a small-cap high-growth stock; LNTH is a small-cap quality compounder stock; RNW is a small-cap high-growth stock; AGEN is a small-cap quality compounder stock; GE is a large-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

TLX

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 106%
  • Gross Margin > 36%
Run This Screen
Stocks Like

LNTH

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 10%
Run This Screen
Stocks Like

RNW

High-Growth Disruptor

  • Sector: Utilities
  • Market Cap > $100B
  • Revenue Growth > 18%
  • Net Margin > 5%
Run This Screen
Stocks Like

AGEN

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 13%
  • Gross Margin > 21%
Run This Screen
Stocks Like

GE

High-Growth Compounder

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 12%
  • Net Margin > 10%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform TLX and LNTH and RNW and AGEN and GE on the metrics below

Revenue Growth>
%
(TLX: 213.9% · LNTH: 1.2%)
Net Margin>
%
(TLX: 4.0% · LNTH: 18.0%)
P/E Ratio<
x
(TLX: 105.7x · LNTH: 27.3x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.